Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.12 EUR | +2.22% | +4.44% | +14.12% |
07:58pm | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
07:00pm | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
Sales 2024 * | 31.48B 39.41B 36.71B | Sales 2025 * | 33.38B 41.79B 38.92B | Capitalization | 66.85B 83.69B 77.95B |
---|---|---|---|---|---|
Net income 2024 * | 5.66B 7.09B 6.61B | Net income 2025 * | 6.4B 8.01B 7.46B | EV / Sales 2024 * | 2.51 x |
Net Debt 2024 * | 12.17B 15.23B 14.19B | Net Debt 2025 * | 8.93B 11.18B 10.42B | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
11.8
x | P/E ratio 2025 * |
10.5
x | Employees | 70,212 |
Yield 2024 * |
3.72% | Yield 2025 * |
3.97% | Free-Float | 92.58% |
Latest transcript on GSK plc
1 day | +2.22% | ||
1 week | +4.44% | ||
Current month | -4.06% | ||
1 month | -2.86% | ||
3 months | +6.86% | ||
6 months | +12.53% | ||
Current year | +14.12% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Urs Rohner
BRD | Director/Board Member | 65 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 19.04 | +1.82% | 3 643 |
24-04-24 | 18.7 | -1.66% | 647 |
24-04-23 | 19.02 | +1.01% | 278 |
24-04-22 | 18.82 | +2.03% | 116 |
24-04-19 | 18.45 | +1.21% | 271 |
Delayed Quote Deutsche Boerse AG, April 25, 2024 at 12:02 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.23% | 358B | |
+20.04% | 322B | |
+8.01% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.51% | 149B | |
-6.37% | 146B |
- Stock Market
- Equities
- GSK Stock
- GS71 Stock